Navigation

POS

Increase Efficiency and Yield in Established and Developing Cell Lines

Improve Aspects of Bioproduct Development by Leveraging Cutting-Edge Technical and Process Innovation

June 13-15, 2016
Parc 55 Hilton
San Francisco, CA

Event Overview

Event Overview

 

Where the bioproduct development community gathers to:

  • Improve Quality, Stability, and Clonality
    • New Unpublished Data from Bristol-Myers Squibb, University of Manitoba, Pfizer Inc.,University of Lausanne, and more
    • Learn to Optimizing Techniques for Mass Spectrometry Detection
    • See how Amgen Utilizes small molecule cell cycle inhibitors to improve product quality of recombinant proteins
  • Hear Updates on Novel High Throughput Technology
    • Discover how NIH and Lonza are utilizing platforms for agressive timeline reduction
    • Learn best strategies to achieve cGMP and critical quality attributes
    • Standardize and Improve clone generation and selection protocols
  • Explore Alternative Host Cell Lines
    • Learn more about Vankyrin-enhanced Sf9 insect cells, glycoengineered human cell lines, and target integrated CHO host cell lines.
    • Improve clinical efficacy and reduce side affects by optimizing glycosylation of antibodies and non-antibody biotherapeutics
    • Discover how to delay apoptosis and increase protein production with the baculovirus expression vector system

View the Agenda

Improve the speed of cell line development, minimize risk, and increase process and product quality with a world-renowned speaking faculty

  • Yongping Crawford, PhD. photo Yongping Crawford, PhD. Scientist, ESCC, Genentech
  • Niall Barron, PhD. photo Niall Barron, PhD. Director, National Institute for Cellular Biotechnology, Dublin City University
  • Elizabeth H. Scheideman photo Elizabeth H. Scheideman Scientist, Cell Line Development, Vaccine Production Program, NIH
  • Xiangguo Qiu, MD photo Xiangguo Qiu, MD Head, Vaccine Development & Antiviral Therapy, Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada

Join the industry's leading Cell Line Development Conference

  • 150+ Attendees
  • 15+ New Data sessions
  • 10+ Hours of Dedicated Networking

Networking Opportunities

Sponsors and Exhibitors

Position yourself as a thought leader and showcase your innovations to an engaged community of scientists and researchers. Contact Patricia Rose at prose@ibcusa.com to receive the sponsor prospectus and to discuss custom packages.

Showcase at the Event

Unite discovery, research and development

  • Access 80+ New Data And Case Study Presentations
    Cell Line Development & Engineering is co-located with Next Generation Protein Therapeutics and Bioconjugates: From Targets to Therapeutics resulting in a unique collaborative experience where experts share insights and inspiring data.
  • All-Access Pass Upgrade
    When you upgrade to the all-access pass you open up a world of opportunity. Prepare for new molecules coming down the pipeline so that you can propel candidates through development and into the clinic efficiently
  • Connect with 400+ Attendees
    Meet over 400 bioproduction professionals through the shared exhibit hall, poster presentations and roundtable discussions. Cross-collaborate for success.
  • A Team Experience
    With so much content packed into three days, you'd need to bring your team to cover it all. Group discounts are available.

Co-Located Events

Footer

Javascript